(Q43846877)

27 November 2017

title

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase (English)

1 reference

27 November 2017

Inmaculada Rioja

1

1 reference

27 November 2017

M Carmen Terencio

2

1 reference

27 November 2017

Amalia Ubeda

3

1 reference

27 November 2017

Pedro Molina

4

1 reference

27 November 2017

Alberto Tárraga

5

1 reference

27 November 2017

Antonia Gonzalez-Tejero

6

1 reference

27 November 2017

M José Alcaraz

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

European Journal of Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

434

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

177-185

1 reference

Effect of a 5-lipoxygenase inhibitor on nerve growth factor-induced thermal hyperalgesia in the rat

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Nociception in cyclooxygenase isozyme-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

1 reference

7 January 2021

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

COX-2 in brain and spinal cord implications for therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-buty1-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: discovery and variation of the 5-keto substituent

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Involvement of prostaglandins produced by cyclooxygenase-1 in murine visceronociception induced by phenylquinone

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Leukotriene B4Produces Hyperalgesia That Is Dependent on Polymorphonuclear Leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Designing therapeutically effective 5-lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Pharmacological analysis of cyclooxygenase-1 in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Anti-inflammatory testing methods: Comparative evaluation of mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Involvement of leukotriene B4 in murine dermatitis models

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Mechanism of action of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901539-4

7 January 2021

10.1016/S0014-2999(01)01539-4

Identifiers

DOI

0 references

1 reference